Interrogating Therapeutic Agents with Additive or Synergistic Activity against HBV for Combination Therapy

Time: 9:00 am
day: Day One


• Advancing combinations exploring a core inhibitor with multiple other mechanisms

• Combining three or more therapeutic candidates with differing mechanisms of action in cross-company collaborations

• Exploring opportunities for future development to attain finite and curative treatment